Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance A. Gil-Núñez; J. Masjuan; J. Montaner; M. Castellanos; T. Segura; P. Cardona; J.I. Tembl; F. Purroy; J. Arenillas; E. Palacio;

Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease J. Masjuan; J. Gállego; J.M. Aguilera; J.F. Arenillas; M. Castellanos; F. Díaz; J.C. Portilla; F. Purroy;

The current situation of Telestroke in Spain A. Barragán-Prieto; S. Pérez-Sánchez; M. Castellanos; A. González; J. Montaner;